Lianyungang, China

Junshan Luo

This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junshan Luo. Retrieved from https://idiyas.com/inventor/junshan-luo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junshan Luo: Innovator in Pharmaceutical Chemistry

Introduction

Junshan Luo is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of inhibitors that target specific cellular pathways. His innovative work has the potential to impact the treatment of various diseases.

Latest Patents

Junshan Luo holds a patent for a preparation method for a CDK4/6 inhibitor. This method involves a compound of formula (I): 5-fluoro-4-(3-isopropyl-2-methyl-2H-indazol-5-yl)-N-(5-(piperazin-1-yl) pyrazol-2-yl)pyrimidine-2-amine. The preparation method utilizes cheap and readily available starting materials and reagents. It greatly simplifies the total reaction steps, shortens the reaction time, and improves the total yield and purity of the key intermediate and final product. This method is particularly suitable for industrial production.

Career Highlights

Junshan Luo is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and efficiency in pharmaceutical processes.

Collaborations

He has collaborated with notable colleagues, including Guofeng Liu and Yong Wang, to further enhance the impact of his research in the pharmaceutical industry.

Conclusion

Junshan Luo's contributions to the field of pharmaceutical chemistry, particularly through his innovative patent for a CDK4/6 inhibitor, highlight his role as a key inventor in the industry. His work exemplifies the importance of innovation in developing effective treatments for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…